Sort by
Refine Your Search
-
Listed
-
Program
-
Field
-
Research Assistant on Session Types: Theory and Programming Semantics Fixed-term until 30 September 2026 to start from 1 October 2025 Grade 06: £34,982-£40,855 per annum inclusive of Oxford
-
launched Oxford Programme for Cyber and Technology Policy (OxCTP). Reporting to the Co-Directors of OxCTP, you will manage your own academic research activities and collaborate in the preparation of research
-
About the role We have an exciting opportunity to join the Draper Group in the Department of Paediatrics as our Clinical Research Fellow – Malaria Vaccine Programme. This role is focused
-
Identifying capabilities and shared risks across LLMs and Agents which is funded the Dieter Schartz Foundation. You will be based at 34 St Giles, Oxford, with a planned move to new premises at the Schwarzman
-
Disease Research Programme. This role focuses on advancing early diagnosis and risk stratification in individuals with inherited cardiac conditions through cutting-edge imaging research. The successful
-
Reporting to Prof Thom Wetzer, Director of the Oxford Sustainable Law Programme and Associate Professor of Law and Finance, the postholder will be a legal scholar with a focus on human rights and
-
work effectively. Being enrolled in a PhD programme is preferred but not essential. Excellent communication, organisational, and IT skills are essential, along with the ability to work independently and
-
the universities of Manchester and Oxford. The post-holder will be one of six centre-funded postdoctoral researchers delivering on projects that form our core research programme. They will be a cornerstone of the
-
About the role We have an exciting opportunity to join the Wood Lab in the Department of Paediatrics as our Postdoctoral Researcher This role is part of a larger interdisciplinary program focused
-
Baker). The subject of the research project within the Division of Cardiovascular Medicine, University of Oxford is to re-programme immune cells as part of a larger programme to develop novel therapeutics